Molecular Imaging

Molecular imaging is a diagnostic imaging procedure that provides detailed images of how the body is funtioning at the molecular and cellular level. It also includes nuclear imaging.

Philips Dosewise portal allows X-ray radiation dose tracking for individual patients

An example of radiation dose tracking software is Philips Dosewise portal, which allows X-ray radiation dose tracking for individual patients by modality, body region and exam type.

Feature | Radiation Dose Management | June 13, 2017 | Dominic Siewko
In recent years, radiation dose management awareness has heightened across the healthcare industry to address growing...
MIM Software Inc. Announces Updates to MIM Encore
Technology | Remote Viewing Systems | May 31, 2017
May 31, 2017 — MIM Software Inc. recently announced significant updates to its MIM Encore solution for viewing nuclear...
News | Enterprise Imaging | May 25, 2017
May 25, 2017 — At the 2017 annual meeting of the Society for Imaging Informatics in Medicine (SIIM), June 1-3 in...
Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers | May 22, 2017
May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the...
Study Reveals Low Adoption of IAEA Recommendations for Reduced Nuclear Cardiology Radiation Exposure
News | Radiation Dose Management | May 12, 2017
May 12, 2017 — A study in 65 countries has revealed low adoption of International Atomic Energy Agency (IAEA)...
Large Nuclear Cardiology Laboratory Slashes Radiation Dose 60 Percent in Eight Years
News | Radiation Dose Management | May 11, 2017
May 11, 2017 — A large nuclear cardiology laboratory in Missouri has slashed its average radiation dose by 60 percent...
Videos | Cardiovascular Business | May 03, 2017
Kim A. Williams, Sr., M.D., chief of cardiology at Rush University Medical Center, Chicago and former president of both...
Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields
News | Radiopharmaceuticals and Tracers | April 28, 2017
April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the...
Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American...

Physicians will need to use a CMS-certified appropriate use criteria (AUC) clinical decision support software that documents the appropriateness of an imaging order to receive full reimbursement for Medicare patients starting Jan. 1, 2018.

Feature | Cardiac Imaging | April 18, 2017 | Dave Fornell
As part of U.S. healthcare reform efforts, starting Jan. 1, 2018, physicians will be required to document they are...
University of Missouri Research Reactor Files to Start U.S. Production of Medical Isotopes
News | Radiopharmaceuticals and Tracers | April 13, 2017
April 13, 2017 — The University of Missouri Research Reactor (MURR) and its partners Nordion and General Atomics (GA),...
IBA Molecular and Mallinckrodt Nuclear Medicine Merge to Become Curium
News | Radiopharmaceuticals and Tracers | April 11, 2017
April 11, 2017 — IBA Molecular announced that it has merged with previous acquisition Mallinckrodt Nuclear Medicine LLC...
GE Healthcare, HealthTrust, supply agreement, nuclear imaging, radiopharmaceuticals
News | Radiopharmaceuticals and Tracers | April 05, 2017
April 5, 2017 — GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered...
Northwestern Memorial Hospital, MR-PET scanner, first in Illinois, Siemens Biograph mMR
News | PET-MRI | March 31, 2017
March 31, 2017 — Northwestern Memorial Hospital is now home to the Chicago area's first combined magnetic resonance (...
PET imaging, atherosclerotic plaque, inflammation, Ga-68-pentixafor, Technishe Universitat Munchen, Germany

Note the high uptake of Ga-68-pentixafor on multi-planar reconstructions in the organs expressing CXCR4 such as the spleen (red arrows) and adrenal glands (yellow arrows), which was nearly completely blocked by the pre-injection of AMD 3100, a potent CXCR4 inhibitor. Strong accumulation of Ga-68-pentixafor was also found in the kidneys (asterisks) reflecting the renal clearance of the tracer. In addition, high, focal activities were detected in the abdominal aorta (red arrowheads) and right carotid artery (orange arrowheads) of atherosclerotic rabbits, whereas no significant signal could be detected in the non-injured left carotid artery (white arrowheads) of atherosclerotic and control rabbits, as well as in the abdominal aorta and right carotid artery of control rabbits. Furthermore, focal activities detected with PET in atherosclerotic plaques of the abdominal aorta and the right carotid artery decreased significantly when the same rabbit was re-imaged after blocking CXCR4 receptors. Image courtesy of Fabien Hyafil, M.D., Ph.D., Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

News | PET Imaging | March 03, 2017
March 3, 2017 — In the featured article of the March 2017 issue of The Journal of Nuclear Medicine, researchers...